173 related articles for article (PubMed ID: 22925751)
1. Anti-AQP(4) antibody in idiopathic acute transverse myelitis with recurrent clinical course: frequency of positivity and influence in prognosis.
Alvarenga MP; Alvarenga RM; Alvarenga MP; Santos AM; Thuler LC
J Spinal Cord Med; 2012 Jul; 35(4):251-5. PubMed ID: 22925751
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics, prognosis, and seropositivity to the anti-aquaporin-4 antibody in Korean patients with longitudinally extensive transverse myelitis.
Kim SH; Kim SM; Vincent A; Ahn SW; Hong YH; Park KS; Sung JJ; Lee KW
J Neurol; 2010 Jun; 257(6):920-5. PubMed ID: 20049472
[TBL] [Abstract][Full Text] [Related]
3. Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-aquaporin 4 antibodies.
Chang KH; Lyu RK; Chen CM; Wu YR; Chang HS; Huang CC; Kuo HC; Chu CC; Hsu WC; Ro LS
Mult Scler; 2013 Mar; 19(3):299-307. PubMed ID: 22829325
[TBL] [Abstract][Full Text] [Related]
4. Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.
Kitley J; Leite MI; Küker W; Quaghebeur G; George J; Waters P; Woodhall M; Vincent A; Palace J
JAMA Neurol; 2013 Nov; 70(11):1375-81. PubMed ID: 23999580
[TBL] [Abstract][Full Text] [Related]
5. Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies.
Iorio R; Damato V; Mirabella M; Evoli A; Marti A; Plantone D; Frisullo G; Batocchi AP
J Neurol; 2013 Sep; 260(9):2396-402. PubMed ID: 23793787
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease.
Lechner C; Baumann M; Hennes EM; Schanda K; Marquard K; Karenfort M; Leiz S; Pohl D; Venkateswaran S; Pritsch M; Koch J; Schimmel M; Häusler M; Klein A; Blaschek A; Thiels C; Lücke T; Gruber-Sedlmayr U; Kornek B; Hahn A; Leypoldt F; Sandrieser T; Gallwitz H; Stoffels J; Korenke C; Reindl M; Rostásy K
J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):897-905. PubMed ID: 26645082
[TBL] [Abstract][Full Text] [Related]
7. A recurrent longitudinally extensive transverse myelitis with Aquaporin-4(AQP4) antibody after herpes zoster.
Park JS; Hwang SJ; Shin JH; Kim DS
J Neurol Sci; 2013 Nov; 334(1-2):69-71. PubMed ID: 23953947
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of aquaporin-4 antibody in longitudinally extensive transverse myelitis.
Wang J; Li X; Zhang DQ; Yang CS; Qi Y; Li MS; Shi FD; Yang L
J Neuroimmunol; 2015 Jan; 278():26-9. PubMed ID: 25595249
[TBL] [Abstract][Full Text] [Related]
9. Longitudinally extensive transverse myelitis immune-mediated in aquaporin-4 antibody negative patients: Disease heterogeneity.
Carnero Contentti E; Hryb JP; Morales S; Gomez A; Chiganer E; Di Pace JL; Lessa C; Perassolo M
J Neurol Sci; 2017 Feb; 373():134-137. PubMed ID: 28131170
[TBL] [Abstract][Full Text] [Related]
10. Study of Clinicoradiological Profile and Prognosis of Longitudinally Extensive Transverse Myelitis from a Single Tertiary Center in Eastern India.
Sahoo LK; Mallick AK; Mohanty G; Swain KP; Nayak SD; Rout P
Neurol India; 2020; 68(5):1079-1083. PubMed ID: 33109856
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications.
Cobo-Calvo Á; Sepúlveda M; Bernard-Valnet R; Ruiz A; Brassat D; Martínez-Yélamos S; Saiz A; Marignier R
Mult Scler; 2016 Mar; 22(3):312-9. PubMed ID: 26209592
[TBL] [Abstract][Full Text] [Related]
12. Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies.
Maillart E; Durand-Dubief F; Louapre C; Audoin B; Bourre B; Derache N; Ciron J; Collongues N; de Sèze J; Cohen M; Lebrun-Frenay C; Hadhoum N; Zéphir H; Deschamps R; Carra-Dallière C; Labauge P; Kerschen P; Montcuquet A; Wiertlewski S; Laplaud D; Runavot G; Vukusic S; Papeix C; Marignier R;
J Neuroinflammation; 2020 Apr; 17(1):128. PubMed ID: 32326965
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis.
Hyun JW; Kim SH; Huh SY; Kim W; Yun J; Joung A; Sato DK; Fujihara K; Kim HJ
Mult Scler; 2015 May; 21(6):710-7. PubMed ID: 25305252
[TBL] [Abstract][Full Text] [Related]
14. The clinical course of idiopathic acute transverse myelitis in patients from Rio de Janeiro.
Alvarenga MP; Thuler LC; Neto SP; Vasconcelos CC; Camargo SG; Alvarenga MP; Papais-Alvarenga RM
J Neurol; 2010 Jun; 257(6):992-8. PubMed ID: 20127351
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Clinical Outcomes of Transverse Myelitis Among Adults With Myelin Oligodendrocyte Glycoprotein Antibody vs Aquaporin-4 Antibody Disease.
Mariano R; Messina S; Kumar K; Kuker W; Leite MI; Palace J
JAMA Netw Open; 2019 Oct; 2(10):e1912732. PubMed ID: 31596489
[TBL] [Abstract][Full Text] [Related]
16. Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study.
Asgari N; Skejoe HP; Lillevang ST; Steenstrup T; Stenager E; Kyvik KO
BMC Neurol; 2013 Apr; 13():33. PubMed ID: 23566260
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].
Yang Y; Wu WP; Huang DH; Wu L
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3032-5. PubMed ID: 23328372
[TBL] [Abstract][Full Text] [Related]
18. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
Mader S; Gredler V; Schanda K; Rostasy K; Dujmovic I; Pfaller K; Lutterotti A; Jarius S; Di Pauli F; Kuenz B; Ehling R; Hegen H; Deisenhammer F; Aboul-Enein F; Storch MK; Koson P; Drulovic J; Kristoferitsch W; Berger T; Reindl M
J Neuroinflammation; 2011 Dec; 8():184. PubMed ID: 22204662
[TBL] [Abstract][Full Text] [Related]
19. The absence of antibodies in longitudinally extensive transverse myelitis may predict a more favourable prognosis.
Rocchi C; Forcadela M; Kelly P; Linaker S; Gibbons E; Bhojak M; Jacob A; Hamid S; Huda S
Mult Scler; 2024 Mar; 30(3):345-356. PubMed ID: 38258822
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China.
Yang CS; Zhang DQ; Wang JH; Jin WN; Li MS; Liu J; Zhang CJ; Li T; Shi FD; Yang L
CNS Neurosci Ther; 2014 Jan; 20(1):32-9. PubMed ID: 23890015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
